FDA.reportPublic FDA data

maribavir 200 MG Oral Tablet

RxCUI
2586073
RxNorm name
maribavir 200 MG Oral Tablet
Display name
maribavir 200 MG Oral Tablet
Full name
maribavir 200 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:21

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LivtencityMARIBAVIRTakeda Pharmaceuticals America, Inc.c94fc2c5-e840-4f18-b7d8-d5eacb26d3a02026-01-27Warnings, Adverse reactionsExact identifier
rxcui: 2586073

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
c94fc2c5-e840-4f18-b7d8-d5eacb26d3a0maribavir 200 MG Oral Tablet [PSN] · maribavir 200 MG Oral Tablet [SCD]214These highlights do not include all the information needed to use LIVTENCITY safely and effectively. See full prescribing information for LIVTENCITY. LIVTENCITY ® (maribavir) tablets, for oral use Initial U.S. Approval: 202120260127